Skip to main content

Featured

Bank of Canada Rate Decision: What to Expect on June 10

  On Wednesday, June 10, 2026 , the Bank of Canada will announce its next interest rate decision — and every Canadian with a mortgage, a savings account, or a variable-rate line of credit has good reason to pay attention. While a hold at the current 2.25% overnight rate is almost universally expected, the real story this month isn't the number itself. It's the language surrounding it. Canada's economy has slipped into what many are calling a technical recession, inflation is being pushed higher by a global energy shock, and economists are divided on where rates go from here. Here's everything you need to know before Wednesday's announcement. BoC Overnight Rate 2.25% Held since early 2026 Bank Prime Rate 4.45% Most major lenders April CPI Inflation 2.8% Up from 2.4% in March Hike Probability (Jun 10) ~4% Per bond markets Q1 2026 GDP Growth −0.1% Annualized; near-recession Where Things Stand: A Tricky Balancing Act The Bank of Canada has held its overnight rate at 2....
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment